Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$17.0 - $25.43 $850,000 - $1.27 Million
50,000 Added 50.0%
150,000 $2.9 Million
Q3 2022

Nov 01, 2022

BUY
$7.67 - $24.23 $767,000 - $2.42 Million
100,000 New
100,000 $2.09 Million
Q3 2020

Nov 13, 2020

SELL
$21.54 - $29.53 $775,440 - $1.06 Million
-36,000 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$21.3 - $35.26 $766,800 - $1.27 Million
36,000 New
36,000 $1.17 Million

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.